BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5980803)

  • 1. [Intoxication psychosis following the administration of scopolamine drops into the conjunctival sac].
    Krynyckyj V; Janovský F; Sedivec V
    Cesk Psychiatr; 1966 Dec; 62(6):405-8. PubMed ID: 5980803
    [No Abstract]   [Full Text] [Related]  

  • 2. Ocular scopolamine-induced psychosis.
    Birkhimer LJ; Jacobson PA; Olson J; Goyette DM
    J Fam Pract; 1984 Mar; 18(3):464, 466, 469. PubMed ID: 6699585
    [No Abstract]   [Full Text] [Related]  

  • 3. Systemic effects of eye drops.
    Davidson SI
    Trans Ophthalmol Soc U K (1962); 1974 Jul; 94(2):487-95. PubMed ID: 4143267
    [No Abstract]   [Full Text] [Related]  

  • 4. Scopolamine psychosis revisited.
    Cairncross JG
    Ann Neurol; 1983 May; 13(5):582. PubMed ID: 6870212
    [No Abstract]   [Full Text] [Related]  

  • 5. Toxic effect of scopolamine eye drops in children.
    Hamborg-Petersen B; Nielsen MM; Thordal C
    Acta Ophthalmol (Copenh); 1984 Jun; 62(3):485-8. PubMed ID: 6464693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Scopolamine plaster caused hallucination. Toxic psychosis in a 10-year-old boy caused by an agent against motion sickness].
    Björk M; Wettergren B
    Lakartidningen; 1995 Feb; 92(7):638. PubMed ID: 7861858
    [No Abstract]   [Full Text] [Related]  

  • 7. Toxic psychosis from sleeping medicines containing scopolamine.
    Bernstein S; Leff R
    N Engl J Med; 1967 Sep; 277(12):638-9. PubMed ID: 4378229
    [No Abstract]   [Full Text] [Related]  

  • 8. [A draftee got a CNS disorder after treatment with scopolamine plaster].
    Olevik P
    Lakartidningen; 1987 Apr; 84(17):1463. PubMed ID: 3586788
    [No Abstract]   [Full Text] [Related]  

  • 9. Scopolamine-induced acute brain syndrome.
    Goldstein BJ
    J Fla Med Assoc; 1966 May; 53(5):413-4. PubMed ID: 5909711
    [No Abstract]   [Full Text] [Related]  

  • 10. Psychosis due to transdermally administered scopolamine.
    MacEwan GW; Remick RA; Noone JA
    CMAJ; 1985 Sep; 133(5):431-2. PubMed ID: 4027811
    [No Abstract]   [Full Text] [Related]  

  • 11. Toxic psychosis from transdermal scopolamine in a child.
    Sennhauser FH; Schwarz HP
    Lancet; 1986 Nov; 2(8514):1033. PubMed ID: 2877187
    [No Abstract]   [Full Text] [Related]  

  • 12. Transdermal scopolamine and toxic psychosis.
    Rodysill KJ; Warren JB
    Ann Intern Med; 1983 Apr; 98(4):561. PubMed ID: 6838088
    [No Abstract]   [Full Text] [Related]  

  • 13. Transderm-induced psychosis in Parkinson's disease.
    Minagar A; Shulman LM; Weiner WJ
    Neurology; 1999 Jul; 53(2):433-4. PubMed ID: 10430448
    [No Abstract]   [Full Text] [Related]  

  • 14. Transdermal scopolamine as a cause of transient psychosis in two elderly patients.
    Mego DM; Omori JM; Hanley JF
    South Med J; 1988 Mar; 81(3):394-5. PubMed ID: 3347867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An unusual case of psychosis caused by long-term administration of a scopolamine membrane patch. Paranoid hallucinogenic and delusional symptoms].
    Rubner O; Kummerhoff PW; Haase H
    Nervenarzt; 1997 Jan; 68(1):77-9. PubMed ID: 9132625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal scopolamine intoxication in a child.
    Klein BL; Ashenburg CA; Reed MD
    Pediatr Emerg Care; 1985 Dec; 1(4):208-9. PubMed ID: 3842169
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial.
    Avunduk AM; Tekelioglu Y; Turk A; Akyol N
    Clin Ther; 2005 Sep; 27(9):1392-402. PubMed ID: 16291412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transderm-induced psychosis in Parkinson's disease.
    Quinn N
    Neurology; 2000 May; 54(9):1877. PubMed ID: 10802809
    [No Abstract]   [Full Text] [Related]  

  • 19. Belladonna alkaloid psychosis: a study of scopolamine hydrobromide vs meths copolamine bromide.
    Kuhn JA; Savage GJ
    Del Med J; 1974 May; 46(5):239-42. PubMed ID: 4830790
    [No Abstract]   [Full Text] [Related]  

  • 20. Transdermally administered scopolamine.
    Paasuke RT
    CMAJ; 1985 Nov; 133(10):956. PubMed ID: 4063911
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.